Sampre Nutritions returns to profitability in FY26

2 min read     Updated on 29 May 2026, 09:27 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Sampre Nutritions Limited reported a return to profitability for the financial year ended 31 March 2026, with a standalone net profit of ₹386.55 lakh against a net loss of ₹730.92 lakh in the previous year. Total revenue for FY26 rose to ₹4,405.76 lakh from ₹2,549.87 lakh in FY25. For Q4FY26, the company recorded a net profit of ₹182.23 lakh. The Board approved the audited results on 29 May 2026, receiving an unmodified opinion from statutory auditors N G Rao & Associates.

powered bylight_fuzz_icon
41368690

*this image is generated using AI for illustrative purposes only.

Sampre Nutritions Limited returned to profitability in the financial year ended 31 March 2026, reporting a net profit of ₹386.55 lakh compared to a net loss of ₹730.92 lakh in the previous year. The turnaround was driven by a significant increase in total revenue, which rose to ₹4,405.76 lakh from ₹2,549.87 lakh in FY25. For the quarter ended 31 March 2026 (Q4FY26), the company posted a net profit of ₹182.23 lakh, reversing the net loss of ₹714.29 lakh recorded in the corresponding quarter of the previous year.

The Board of Directors approved the standalone and consolidated audited financial results for the quarter and year ended 31 March 2026 at a meeting held on 29 May 2026. The statutory auditors, N G Rao & Associates, issued an audit report with an unmodified opinion on the financial results. The meeting was conducted pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance

The company's operational efficiency improved as total expenses for FY26 increased to ₹4,149.23 lakh from ₹3,266.05 lakh in the prior year, a rise that was outpaced by the revenue growth. Profit before tax for the full year stood at ₹256.53 lakh, a turnaround from the loss before tax of ₹716.18 lakh in FY25. For Q4FY26, profit before tax was ₹52.21 lakh compared to a loss before tax of ₹699.55 lakh in the same period last year.

Particulars Q4FY26 (₹ in Lakhs) Q4FY25 (₹ in Lakhs) FY26 (₹ in Lakhs) FY25 (₹ in Lakhs)
Total Revenue 1,577.77 807.07 4,405.76 2,549.87
Total Expenses 1,525.56 1,506.62 4,149.23 3,266.05
Profit Before Tax 52.21 (699.55) 256.53 (716.18)
Net Profit 182.23 (714.29) 386.55 (730.92)
Basic EPS 0.87 (3.40) 1.84 (3.48)

Consolidated Results

On a consolidated basis, the company reported a net profit of ₹307.67 lakh for FY26, compared to a net loss of ₹767.23 lakh in the previous year. Total consolidated revenue for the year increased to ₹4,377.92 lakh from ₹2,549.87 lakh in FY25. For the quarter ended 31 March 2026, the consolidated net profit was ₹134.59 lakh. The financial results include the performance of subsidiaries Sampre Nutritions Holding Limited and Sampre Nutritions-FZCO.

Historical Stock Returns for Sampre Nutritions

1 Day5 Days1 Month6 Months1 Year5 Years
+0.73%-17.93%-35.61%-58.09%+76.48%+137.20%

What specific strategic initiatives drove the 72% revenue surge, and are these growth rates sustainable for FY27?

How will the company utilize its restored profitability to fund future expansion or reduce existing debt?

What are the growth projections for the subsidiaries, Sampre Nutritions Holding Limited and Sampre Nutritions-FZCO, in the coming year?

Sampre Nutritions Shareholders Approve Poddar as Non-Executive Director via Postal Ballot

3 min read     Updated on 12 May 2026, 04:49 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Sampre Nutritions Limited successfully completed its postal ballot process, with shareholders approving the appointment of Pradeep Narendra Poddar (DIN: 00025199) as Non-Executive Non-Independent Director liable to retire by rotation. Remote e-voting concluded on 10 May 2026, with 13,581,902 votes (99.99%) cast in favour and only 141 votes against, out of a total paid-up equity share capital comprising 95,008,913 shares. The scrutinizer's report was issued on 12 May 2026 by Akshita Surana of Akshita Surana & Associates.

powered bylight_fuzz_icon
40130080

*this image is generated using AI for illustrative purposes only.

Sampre Nutritions Limited has successfully completed its postal ballot process, with shareholders approving the appointment of Pradeep Narendra Poddar (DIN: 00025199) as a Non-Executive Non-Independent Director liable to retire by rotation. The resolution was passed with an overwhelming majority through remote e-voting, concluding on 10 May 2026. The outcome was communicated to BSE Limited on 12 May 2026 by Brahma Gurbani, Managing Director (DIN: 00318180).

Postal Ballot Process and Key Dates

The Company initiated the postal ballot process through a notice dated 10 April 2026, seeking member approval via remote e-voting. The following table outlines the key dates and parameters of the process:

Parameter: Details
Notice Date: 10 April 2026
Record Date: 03 April 2026
E-Voting Commencement: 11 April 2026 at 9:00 A.M. (IST)
E-Voting Conclusion: 10 May 2026 at 5:00 P.M. (IST)
Scrutinizer's Report Date: 12 May 2026
Total Shareholders on Record Date: 7,162

The postal ballot notice was advertised in Financial Express (English) and Nava Telangana (Telugu) in their editions dated Saturday, 11 April 2026. The e-voting facility was provided by the National Securities Depository Limited (NSDL) as the authorised service provider.

Scrutinizer Appointment and Oversight

The Board of Directors appointed Akshita Surana as the Scrutinizer for conducting the remote e-voting process in a fair and transparent manner. The scrutinizer's details are as follows:

Parameter: Details
Scrutinizer Name: Akshita Surana
Firm Name: Akshita Surana & Associates
Qualification: CS
Membership Number: F12130
Certificate of Practice No.: 20704
Firm Registration No.: S2023TS910600
Date of Appointment by Board: 13 February 2026
Date of Report Issuance: 12 May 2026

The scrutinizer verified all votes cast through remote e-voting based on data generated from the NSDL portal, ensuring compliance with applicable MCA Circulars and SEBI Circulars, as well as Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Share Capital and Voting Entitlement

The total paid-up equity share capital of the Company as on the cut-off date of 03 April 2026, available for e-voting, was INR 47,50,44,565 (Indian Rupees Forty-seven crores fifty lakhs forty-four thousand five hundred sixty-five) only, comprising 95008913 fully paid-up equity shares having a face value of INR 5 each.

Voting Results: Resolution No. 1

The sole resolution put to vote concerned the appointment of Pradeep Narendra Poddar as a Non-Executive Non-Independent Director. The promoter and promoter group are not interested in the agenda. The detailed voting results are presented below:

Category: Shares Held Votes Polled % Polled Votes in Favour Votes Against % in Favour % Against
Promoter & Promoter Group: 13336652 13335852 99.994 13335852 0 100 0
Public – Institutions: 411000 0 0 0 0 0 0
Public – Non Institutions: 81261261 246191 0.303 246050 141 99.9427 0.0573
Total: 95008913 13582043 14.2955 13581902 141 99.999 0.001

The resolution was voted upon by 92 members through remote e-voting, with 13,581,902 votes cast in favour (99.99%) and 141 votes against (0.00%), with zero invalid votes recorded.

Resolution Outcome

The Ordinary Resolution for the appointment of Pradeep Narendra Poddar (DIN: 00025199) as a Non-Executive Non-Independent Director liable to retire by rotation has been duly passed with the requisite majority. The voting results and the Scrutinizer's Report have been placed on the Company's website at https://gurbanigroup.in/ . All electronic data and relevant records relating to the e-voting are under the scrutinizer's custody and will be handed over to the Company Secretary.

Historical Stock Returns for Sampre Nutritions

1 Day5 Days1 Month6 Months1 Year5 Years
+0.73%-17.93%-35.61%-58.09%+76.48%+137.20%

How might Pradeep Narendra Poddar's expertise and background influence Sampre Nutritions' strategic direction and business expansion plans going forward?

Given the notably low public institutional voting participation (0% of 411,000 shares polled), what does this suggest about institutional investor engagement with Sampre Nutritions and how could this impact future governance decisions?

With only 14.3% of total shares participating in the e-voting process, what steps might Sampre Nutritions take to improve shareholder participation in future corporate governance exercises?

More News on Sampre Nutritions

1 Year Returns:+76.48%